Positive data readouts from outcome trials, a head start in negotiating access for these drugs with PBMs, and long lead times to ramp up manufacturing all contribute to a very significant competitive moat for both LLY and NVO as the GLP-1 market rapidly grows over the next decade
While the implications for SARM1 in regulating axonal fate are well-established, the sensing mechanisms of this protein complex toward NAD + , NMN, or even possibly toward other NAD + metabolites are not fully understood, and may suggest that also the other NAD + metabolites could regulate more biological processes than initially thought 54
Start with the manufacturers official communications, regulator updates, and recognized trial registries
Regular follow-up appointments at our Coral Springs location ensure your GLP-1 program stays on track, with dosage adjustments as needed to maintain momentum toward your weight loss goals
Aging, stem cells and tissue regeneration: Lessons from muscle